Written by: Jonathan Alsop, PhD | Posted on: 11-01-2021 | Category: MAICMatching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerThis recently published MAIC is an interesting one. The authors have clearly gone to great lengths to identify and adjust for potential treatment-effect ...Read More
